Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Trial details
- Registry ID
- NCT06777433
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesNCT06777433 | RADX | Phase 2 | Active not recruiting | 2026-04-23Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |